The Hormones in Dosage Except Contraceptives and Antibiotics market in Mexico has shown a decreasing trend over the past decade, with a notable decline from $6.42 in 2013 to $4.10 in 2023. The market experienced a slight recovery from 2016 to 2020, but this was not sustained. The year-on-year variation shows a decline of approximately 3.1% between 2022 and 2023. The compound annual growth rate (CAGR) over the last five years is approximately -2.8%, indicating a steady downward trajectory for the period.
Future trends to watch for include potential impacts of new hormonal therapies entering the market, shifts in healthcare policies, and consumer preferences. Additionally, potential innovations in biotechnology and personalized medicine may influence market developments.
